IRVINE, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , a global leader in medical technologies to treat advanced cardiovascular disease, plans to announce its operating results for the quarter ended September 30, 2005 after the market closes on Tuesday, October 25, 2005 and will host a conference call at 5:00pm EDT that day to discuss its results.
To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 172895. The call will also be available via live or archived webcast on the “Investor Relations” section of the Edwards’ web site at www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.
About Edwards Lifesciences
Edwards Lifesciences, a global leader in medical technologies to treat advanced cardiovascular disease, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. The company’s global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, Fogarty, LifeStent, PERIMOUNT, and Swan-Ganz. Additional company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT, and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the U.S. Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the U.S. Patent and Trademark Office.
Edwards Lifesciences Corporation
CONTACT: Media, Barry R. Liden, +1-949-250-5070, or Investors, David K.Erickson, +1-949-250-6826, both of Edwards Lifesciences Corporation
